Pagina de pornireA1LN34 • BVMF
add
Alnylam Pharmaceuticals Inc Bdr
Închidere anterioară
85,74 R$
Interval anual
65,75 R$ - 87,01 R$
Capitalizare bursieră
42,09 mld. USD
Volum mediu
64,00
La știri
Despre
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Director executiv
Înființare
14 iun. 2002
Site
Angajați
2.230
